DUBLIN, Nov. 14, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the winner of the Extracorporeal Immunomodulation Award (EIA). The award recognizes a ...
Investigators assessed tolerability, safety, and efficacy of low-intensity extracorporeal shock wave therapy for treating mild to moderate SUI in women.
AEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
The following is a summary of “Vascular Complications After Venoarterial Extracorporeal Membrane Oxygenation Support: A CT Study,” published in the November 2024 issue of Critical Care by Djavidi et ...
Over the last decade, extracorporeal membrane oxygenation, previously considered unsuitable for oncologic patients, has become increasingly popular, with more diverse applications. Nevertheless, ...